FindTrial
Sign In

Noninvasive chromosome screening(NICS) of human embryos by genome sequencing of embryo culture medium for in vitro fertilization: a multicenter-clinical trial, assessment of NICS technology.

Noninvasive chromosome screening(NICS) of human embryos by genome sequencing of embryo culture medium for in vitro fertilization: a multicenter-clinical trial

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17010376
Enrollment
Unknown
Registered
2017-01-11
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

screening of human embryos by genome sequencing

Interventions

Gold Standard:traditional invasive biopsy of human embyos
Index test:NICS&#32
of&#32
human&#32
embryos&#32
by&#32
genome&#32
sequencing&#32
embryo&#32
culture&#32
medium&#32

Sponsors

Nanjing General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1) discard embryos in ICSI treatment cycle or embryos for PGS or PGD; 2) be willing to participate in this study and to sign informed consent.

Exclusion criteria

Exclusion criteria: patients with contraindications for assisted reproductive technology

Design outcomes

Primary

MeasureTime frame
Sen, Spe, Acc;—

Countries

China

Contacts

Public ContactBING YAO
yaobing@nju.edu.cn13815853296

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026